Operating Company Healthcare

Headlands Research

Lake Worth, Florida, United States

Globally integrated clinical research site organization comprised of dedicated and embedded research centers across North America, conducting 5,000+ Phase I–IV trials to advance innovative medical therapies.

Focus Areas
Clinical trial site operations, Dedicated and embedded research centers, Phase I–IV clinical research

Tracked deals

11

11 tracked deals across 2021-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Addon

8 addon · 3 buyout

Headlands Research Acquisition Volume by Year

Last 6 years

Acquisition volume by year Annual acquisition counts for the last 6 years for Headlands Research. 2 2021 1 2022 4 2023 2 2024 1 2025 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Headlands Research, THL Partners (mentioned as backing Headlands Research)
    Target
    Clinical Trials Research (CTR)
    Type
    Buyout

    Headlands Research announced the acquisition of Clinical Trials Research (CTR), a privately owned clinical research organization with locations in Sacramento and Lincoln, California. The sites will be rebranded as Headlands Research – Sacramento and Headlands Research – CTR Lincoln, expanding Headlands’ California presence and cardiometabolic therapeutic area capabilities. Financial terms were not disclosed.

  • Buyer
    Headlands Research
    Target
    CMRCenter
    Location
    Puerto Rico, United States
    Type
    Addon

    Headlands Research has acquired CMRCenter (CMRC), a high-performing clinical research site in San Juan, Puerto Rico, expanding Headlands' site network into the Caribbean and bringing its footprint to 22 sites across the United States, Canada, and Puerto Rico. The deal provides biopharma sponsors a single-contract gateway to a large Hispanic patient population and is intended to accelerate enrollment for vaccine, CNS, and specialty studies.

  • Buyer
    Headlands Research
    Target
    Trial Management Associates
    Type
    Addon

    Headlands Research has acquired Trial Management Associates (TMA), a multi-site clinical research company with locations in Wilmington, North Carolina and Myrtle Beach, South Carolina. The deal expands Headlands Research's network to 21 sites across the United States and Canada and strengthens its southeastern U.S. footprint and clinical capabilities.

  • Buyer
    Headlands Research
    Target
    Pharmasite Research
    Type
    Addon

    Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.

  • Buyer
    Headlands Research
    Target
    Clinical Research Professionals
    Type
    Addon

    Headlands Research has acquired Clinical Research Professionals, a St. Louis–area clinical research site, expanding Headlands' network and geographic reach. The acquisition adds experienced investigators and capabilities across therapeutic areas including gastroenterology, neurology, and vaccines, supporting increased participant recruitment and trial capacity.

  • Buyer
    Headlands Research
    Target
    AMCR Institute
    Type
    Addon

    Headlands Research has acquired AMCR Institute, a San Diego–based clinical research site specializing in metabolic, endocrine and medical device research (including continuous glucose monitors). The site will operate as Headlands Research AMCR Institute as part of Headlands' expanding network of clinical trial sites to support more trials and broaden therapeutic and device capabilities.

  • Buyer
    Headlands Research
    Target
    Clinvest Research
    Seller
    Ryan Cady
    Type
    Buyout

    Headlands Research, a multinational clinical trial site network, has acquired Clinvest Research, a Springfield, Missouri-based clinical research site that has conducted over 600 trials since 1996. The deal expands Headlands' chronic pain and endocrinology capabilities and increases participant access for trials in the United States.

  • Buyer
    Headlands Research
    Target
    Headlands Research Eastern Massachusetts
    Type
    Buyout

    Headlands Research acquired an established clinical research site now operating as Headlands Research Eastern Massachusetts. The site — led by neurologist Dr. Donald Marks and specializing in neurodegenerative diseases such as Alzheimer’s and Parkinson’s — broadens Headlands’ neurology research capabilities and expands its clinical trial site network in Eastern Massachusetts.

  • Buyer
    Headlands Research, KKR & Co. Inc.
    Target
    Peninsula Research Associates
    Type
    Addon

    Headlands Research, a KKR-backed clinical trial site network based in San Francisco, acquired Peninsula Research Associates (PRA) of Rolling Hills, California. The undisclosed transaction expands Headlands' clinical research capabilities in allergy and asthma, pediatric studies and vaccine trials while extending its Southern California footprint.

  • Buyer
    Headlands Research, KKR
    Target
    Summit Research Network
    Type
    Addon

    Headlands Research, a KKR-backed clinical research site organization based in San Francisco, has acquired Summit Research Network in Portland, Oregon, expanding Headlands' site footprint and expertise in neurology, psychiatry and memory-health research. The deal grows Headlands' global network to 15 clinical trial sites and accompanies the launch of a fourth Horizons site in Scottsdale, Arizona.

  • Buyer
    Headlands Research
    Target
    Artemis Institute for Clinical Research
    Type
    Addon

    Headlands Research, a San Francisco–based clinical research site organization backed by KKR, has acquired Artemis Institute for Clinical Research, a multi-site clinical trial provider with locations in San Diego and Riverside, California. The acquisition expands Headlands' global footprint to 13 clinical trial sites and adds Artemis' expertise across psychiatry, neurology, vaccine and medical device trials while supporting Headlands' commitment to diversity in clinical trial enrollment.

Related Acquisition Pages

Selling a company? Get in front of buyers like Headlands Research

Turn tracked acquisition activity into an outreach-ready buyer list.